Increased risk for EBV-lymphoma after allogeneic HSCT in adult lymphoma patients? A retrospective study of reduced compared to myeloablative conditioning.

被引：0
|
作者：
Hagglund, HG
Brune, M
Oberg, G
Hagberg, H
Theorin, N
Remberger, M
Kimby, E
机构：
[1] Karolinska Univ Hosp, Karolinska Inst, Stockholm, Sweden
[2] Sahlgrens Univ Hosp, S-41345 Gothenburg, Sweden
[3] Univ Uppsala Hosp, Uppsala, Sweden
[4] Linkoping Univ Hosp, S-58185 Linkoping, Sweden
[5] Huddinge Univ Hosp, Karolinska Inst, Stockholm, Sweden
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5116
引用
收藏
页码：362B / 363B
页数：2
相关论文
共 50 条
  • [21] Disease status but not histology is predictive of outcome in lymphoma patients after allogeneic stem cell transplantation with reduced-intensity conditioning regimen
    Castagna, L.
    Bouabdallah, R.
    Fuerst, S.
    El Cheikh, J.
    Faucher, C.
    Crocchiolo, R.
    Granata, A.
    Boher, J. M.
    Mohty, M.
    Blaise, D.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S328 - S329
  • [22] Tandem autologous-reduced intensity allogeneic stem cell transplantation in high-risk relapsed Hodgkin lymphoma: a retrospective study of the Lymphoma Working Party—EBMT
    Leyre Bento
    Ariane Boumendil
    Hervé Finel
    Irma Khvedelidze
    Didier Blaise
    Nathalie Fegueux
    Luca Castagna
    Edouard Forcade
    Patrice Chevallier
    Nicola Mordini
    Pauline Brice
    Eric Deconinck
    Martin Gramatzki
    Paolo Corradini
    Mathilde Hunault
    Maurizio Musso
    Anna Tsoulkani
    Dolores Caballero
    Sandro Nati
    Silvia Montoto
    Anna Sureda
    Bone Marrow Transplantation, 2021, 56 : 655 - 663
  • [23] Outcomes after salvage allogeneic stem cell transplantation with myeloablative conditioning FBC in patients with relapsed/refractory mantle cell lymphoma: single-center experience
    Aydilek, E.
    Hasenkamp, J.
    Aperdannier, L.
    Maulhardt, M.
    Mazzeo, P.
    Shumilov, E.
    Wulf, G.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 304 - 305
  • [24] Non-Myeloablative Allogeneic Transplantation with Post-Transplant Cyclophosphamide after Immune Checkpoint Inhibition for Classic Hodgkin Lymphoma: A Retrospective Cohort Study
    Paul, Suman
    Zahurak, Marianna
    Luznik, Leo
    Ambinder, Richard F.
    Fuchs, Ephraim J.
    Bolanos-Meade, Javier
    Wagner-Johnston, Nina
    Swinnen, Lode J.
    Schoch, Laura
    Varadhan, Ravi
    Jones, Richard J.
    Gladstone, Douglas E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (09) : 1679 - 1688
  • [25] SEQUENTIAL CHEMOTHERAPY FOLLOWED BY REDUCED INTENSITY CONDITIONING AND ALLOGENEIC HSCT FOR HIGH RISK AML PATIENTS IN FIRST COMPLETE REMISSION: A PROSPECTIVE PILOT STUDY
    Michallet, M.
    Sobh, M.
    Ducastelle, S.
    Gilis, L.
    Tigaud, I.
    Hayette, S.
    El-Hamri, M.
    Labussiere, H.
    Barraco, F.
    Nicolini, F. E.
    Thomas, X.
    HAEMATOLOGICA, 2014, 99 : 426 - 427
  • [26] Tandem autologous-reduced intensity allogeneic stem cell transplantation in high-risk relapsed Hodgkin lymphoma: a retrospective study of the Lymphoma Working Party-EBMT
    Bento, Leyre
    Boumendil, Ariane
    Finel, Herve
    Khvedelidze, Irma
    Blaise, Didier
    Fegueux, Nathalie
    Castagna, Luca
    Forcade, Edouard
    Chevallier, Patrice
    Mordini, Nicola
    Brice, Pauline
    Deconinck, Eric
    Gramatzki, Martin
    Corradini, Paolo
    Hunault, Mathilde
    Musso, Maurizio
    Tsoulkani, Anna
    Caballero, Dolores
    Nati, Sandro
    Montoto, Silvia
    Sureda, Anna
    BONE MARROW TRANSPLANTATION, 2021, 56 (03) : 655 - 663
  • [27] Day 100 PET Scan Positivity Predicts for Worse Survival in Lymphoma Patients Given Allogeneic Peripheral Blood Stem Cells After Non-Myeloablative Conditioning
    Jaspers, Aurelie
    Fosse, Pacome
    Withofs, Nadia
    Lejeune, Marie
    Willems, Evelyne
    Hafraoui, Kaoutar
    Hustinx, Roland
    Baron, Frederic
    Beguin, Yves
    BLOOD, 2011, 118 (21) : 1777 - 1778
  • [28] Kinetics of HTLV-1 proviral loads after allogeneic hematopoietic stem cell transplantation using reduced intensity conditioning for adult T cell leukemia/lymphoma
    Utsunomiya, Atae
    Tanosaki, Ryuji
    Uike, Naokuni
    Masuda, Masao
    Saburi, Yoshio
    Tomonaga, Masao
    Etoh, Tetsuya
    Kikuchi, Hiroshi
    Harada, Mine
    Kawano, Fumio
    Choi, Ilseung
    Matsuoka, Masao
    Kannagi, Mari
    Sonoda, Shunro
    Okamura, Jun
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2007, 23 (04) : 618 - 618
  • [29] Comparable long-term outcomes after reduced-intensity conditioning versus myeloablative conditioning allogeneic stem cell transplantation for adult high-risk acute lymphoblastic leukemia in complete remission
    Eom, Ki-Seong
    Shin, Seung-Hwan
    Yoon, Jae-Ho
    Yahng, Seung-Ah
    Lee, Sung-Eun
    Cho, Byung-Sik
    Kim, Yoo-Jin
    Kim, Hee-Je
    Min, Chang-Ki
    Kim, Dong-Wook
    Lee, Jong-Wook
    Min, Woo-Sung
    Park, Chong-Won
    Lee, Seok
    AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (08) : 634 - 641
  • [30] Long-term outcome analysis of reduced-intensity allogeneic stem cell transplantation in patients with mantle cell lymphoma: a retrospective study from the EBMT Lymphoma Working Party
    Stephen P. Robinson
    Ariane Boumendil
    Herve Finel
    Karl S. Peggs
    Patrice Chevallier
    Jorge Sierra
    Jürgen Finke
    Xavier Poiré
    Natacha Maillard
    Noël Milpied
    Ibrahim Yakoub-Agha
    Mickey Koh
    Nicolaus Kröger
    Arnon Nagler
    Yener Koc
    Sascha Dietrich
    Silvia Montoto
    Peter Dreger
    Bone Marrow Transplantation, 2018, 53 : 617 - 624
12345